COVID-19 Among Egyptian Health Care Providers

July 4, 2020 updated by: Ahmed Mohamed Abbas, Assiut University

Knowledge, Attitude, Perceived Worry and Stigma About COVID-19 Among Egyptian Health Care Providers

The study aims to identify COVID 19 knowledge, working conditions, perception of anxiety and stigma among Egyptian health care providers as well as their predictors.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

565

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cairo
      • Assiut, Cairo, Egypt, 002
        • Ahmed Abbas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Health care providers include physicians, nurses, and health officers both medical and nursing subjects.

Description

Inclusion Criteria:

  • Health care providers include physicians, nurses, and health officers both medical and nursing subjects.

Exclusion Criteria:

  • Medical students

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
study group
Health care providers include physicians, nurses, and health officers both medical and nursing subjects.
Data will be collected using Google online self-administered questionnaire disseminated in Arabic language

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The percentage of knowledge regarding COVID-19 information
Time Frame: 10 minutes
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 22, 2020

Primary Completion (Actual)

May 26, 2020

Study Completion (Actual)

May 30, 2020

Study Registration Dates

First Submitted

April 21, 2020

First Submitted That Met QC Criteria

April 21, 2020

First Posted (Actual)

April 22, 2020

Study Record Updates

Last Update Posted (Actual)

July 7, 2020

Last Update Submitted That Met QC Criteria

July 4, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • COVIDQ

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID

Clinical Trials on self-administered questionnaire

Subscribe